Breast Cancer

FDA approves computer-aided detection for digital mammography

Published in Cancer Weekly, December 30th, 2003

Fischer Imaging Corporation (FIMG) and R2 Technology, Inc., announced that approval has been granted by the U.S. Food and Drug Administration (FDA) for the use of R2's proprietary mammography CAD technology with Fischer's SenoScan TrueView Digital Scanning Mammography system.

CAD is used by increasing numbers of radiologists as "a second pair of eyes" when reading a woman's mammogram. Analogous to a spell checker system on a personal computer, this technology has the potential to detect findings that might otherwise be overlooked during the review process, thus increasing cancer detection. CAD technology also is especially effective in identifying calcifications, some...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2003-12-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry